Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the target of a large drop in short interest in the month of May. As of May 29th, there was short interest totaling 19,405 shares, a drop of 49.2% from the May 14th total of 38,212 shares. Based on an average trading volume of 24,657 shares, the short-interest ratio is presently 0.8 days. Approximately 0.9% of the shares of the company are short sold.
Institutional Trading of Invesco Nasdaq Biotechnology ETF
Large investors have recently modified their holdings of the company. Independent Advisor Alliance acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF in the 4th quarter worth about $653,000. Orion Porfolio Solutions LLC acquired a new position in Invesco Nasdaq Biotechnology ETF during the 4th quarter valued at about $392,000. CreativeOne Wealth LLC acquired a new position in Invesco Nasdaq Biotechnology ETF during the 4th quarter valued at about $286,000. IHT Wealth Management LLC acquired a new position in Invesco Nasdaq Biotechnology ETF during the 2nd quarter valued at about $211,000. Finally, Raymond James Financial Inc. acquired a new position in Invesco Nasdaq Biotechnology ETF during the 2nd quarter valued at about $149,000.
Invesco Nasdaq Biotechnology ETF Stock Up 0.2%
IBBQ stock opened at $29.57 on Friday. Invesco Nasdaq Biotechnology ETF has a fifty-two week low of $20.67 and a fifty-two week high of $30.50. The firm’s 50-day simple moving average is $29.42 and its 200 day simple moving average is $29.11. The stock has a market cap of $66.83 million, a PE ratio of 17.03 and a beta of 0.62.
Invesco Nasdaq Biotechnology ETF Cuts Dividend
Invesco Nasdaq Biotechnology ETF Company Profile
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Further Reading
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
